Alkermes plc. Undistributed Earnings of Foreign Subsidiaries
Alkermes plc. (ALKS) had Undistributed Earnings of Foreign Subsidiaries of $965.70 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2026-02-25
- 2025-12-31: Undistributed Earnings of Foreign Subsidiaries $965.70M.
- 2024-12-31: Undistributed Earnings of Foreign Subsidiaries $933.50M.
- 2023-12-31: Undistributed Earnings of Foreign Subsidiaries $797.00M.
- 2022-12-31: Undistributed Earnings of Foreign Subsidiaries $812.80M.
| Period end | Undistributed Earnings of Foreign Subsidiaries |
|---|---|
| 2025-12-31 | $965.70M 10-K · filed 2026-02-25 |
| 2024-12-31 | $933.50M 10-K · filed 2025-02-12 |
| 2023-12-31 | $797.00M 10-K · filed 2024-02-21 |
| 2022-12-31 | $812.80M 10-K · filed 2023-02-16 |
| 2021-12-31 | $452.00M 10-K · filed 2022-02-16 |
| 2020-12-31 | $369.00M 10-K · filed 2021-02-11 |
| 2019-12-31 | $418.10M 10-K · filed 2020-02-13 |
| 2018-12-31 | $327.10M 10-K · filed 2019-02-15 |
| 2017-12-31 | $160.30M 10-K · filed 2018-02-16 |
| 2016-12-31 | $133.70M 10-K · filed 2017-02-17 |
| 2015-12-31 | $107.00M 10-K · filed 2016-02-25 |
| 2014-12-31 | $80.40M 10-K · filed 2015-02-24 |
| 2013-12-31 | $53.70M 10-KT · filed 2014-02-27 |
| 2013-03-31 | $39.00M 10-K · filed 2013-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |